z-logo
open-access-imgOpen Access
Genotype in BRCA ‐associated Breast Cancers
Author(s) -
MericBernstam Funda,
GutierrezBarrera Angelica M.,
Litton Jennifer,
MellorCrummey Lauren,
Ready Kaylene,
GonzalezAngulo Ana Maria,
Lu Karen H.,
Hortobagyi Gabriel N.,
Arun Banu K.
Publication year - 2012
Publication title -
the breast journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.533
H-Index - 72
eISSN - 1524-4741
pISSN - 1075-122X
DOI - 10.1111/tbj.12056
Subject(s) - medicine , breast cancer , oncology , genotype , cancer , brca mutation , brca2 protein , ovarian cancer , mutation , germline mutation , gene , genetics , biology
Women with BRCA 1 or 2 mutations are at high risk for breast cancer. For BRCA 1 , a trend of increasing risk has been associated with increasing downstream (3′) location for mutations compared to the upstream (5′) mutations in the gene. For BRCA 2 , an increased risk of breast cancer has been associated with mutations outside of the ovarian cancer cluster region ( OCCR ). We sought to determine the mutation position in BRCA ‐associated breast cancers and whether or not there was a genotype‐phenotype correlation. Breast cancer patients with BRCA 1/2 mutations were identified by a search of a prospectively maintained data base. Mutation site, patient, and tumor characteristics were determined through retrospective review. One hundred and sixty‐four patients with BRCA 1 ‐associated breast cancer and 109 patients with BRCA 2 ‐associated breast cancer were identified. Among patients with BRCA 1 ‐associated cancers, 86 (52%) had mutations in the 5′ half of the gene. Among patients with BRCA 2 ‐associated breast cancers, 40 (37%) had OCCR mutations. Although BRCA 1 ‐associated tumors were more likely to be ER / PR ‐ than BRCA 2 ‐associated cancers (p < 0.0001), there was no difference in the tumor characteristics among BRCA 1 or BRCA 2 ‐associated cancers based on mutation location. In this single‐institution study, over half of BRCA 1 ‐associated and over a third of BRCA 2 ‐associated breast cancers were associated with putative lower risk mutations. Although we cannot exclude the possibility that mutations in these regions confer a lower relative risk for breast cancer, vigilance in cancer screening and prevention remains necessary. Further studies in genotype/phenotype correlation are needed to individualize prevention strategies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here